Susana Lopes

Junior Researcher


Career

  • Since  2019: Junior Researcher, Universidade do Minho

Qualifications

  • 2013: PhD Program in Chemical and Biological Engineering, Universidade do Minho
  • 2007: Integrated Master on Biological Engineering, Universidade do Minho

Laboratory Management

  • Since 2019: Antimicrobial strategies to fight polymicrobial biofilms associated to cystic fibrosis and ventilator-associated pneumonia infections and development of molecular tools (PNA-FISH) for biofilm diagnosis.
  • 2014 - 2019: Development of antimicrobial strategies targeting polymicrobial biofilms formed on the cystic fibrosis airway epithelium
  • 2009 - 2013: Insights into the ecology of polymicrobial biofilms involved in cystic fibrosis

Projects

Past Students


Recent Publications

1
Antimicrobial resistance three ways: healthcare crisis, major concepts, and the relevance of biofilms
  • FEMS Microbiology Ecology, 95(8), fiz115, 2019
2
Antibacterial and anti-biofilm activity of cinnamon essential oil and eugenol
  • Ciência Rural, 49(1), e20180314, 2019
3
Quantitative assessment of individual populations within polymicrobial biofilms
  • Scientific Reports, 8(9494), 2018
4
Developing a model for cystic fibrosis sociomicrobiology based on antibiotic and environmental stress
  • INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 307(8), 460-470, 2017
5
Discriminating between typical and atypical cystic fibrosis-related bacterial species by multiplex PNA-FISH
  • Biotechnology and Bioengineering, 114(2), 355-376, 2017
6
Polymicrobial ventilator-associated pneumonia: fighting in vitro Candida albicans-Pseudomonas aeruginosa biofilms with antifungal-antibacterial combination therapy
  • PLoS One, 12(1), e0170433, 2017
7
Insights into cystic fibrosis polymicrobial consortia: the role of species interactions in biofilm development, phenotype, and response to in-use antibiotics
  • Frontiers in Microbiology, 7(2146), 1-11, 2017
8
The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy
  • Applied Microbiology and Biotechnology, 100(3), 1163-1181, 2016
9
Microbiome in cystic fibrosis - shaping polymicrobial interactions for advances in antibiotic therapy
  • Critical Reviews in Microbiology, 41(3), 353-365, 2015
10
Emergent bacteria in cystic fibrosis: In vitro biofilm formation and resilience under variable oxygen conditions
  • BioMed Research International, 2014(678301), 1-7, 2014
11
Minimum information about a biofilm experiment (MIABiE): standards for reporting experiments and data on sessile microbial communities living at interfaces
  • Pathogens and Disease, 70(3), 250-256, 2014
12
Antibiotic resistance of mixed biofilms in cystic fibrosis: Impact of emerging microorganisms on treatment of infection
  • International Journal of Antimicrobial Agents, 40(3), 260-263, 2012
13
Antimicrobial pressure of ciprofloxacin and gentamicin on biofilm development by an endoscope-isolated Pseudomonas aeruginosa
  • ISRN Biotechnology, 2013(178646), 1-10, 2012
14
Adaptive response of single and binary Pseudomonas aeruginosa and Escherichia coli biofilms to benzalkonium chloride
  • Journal of Basic Microbiology, 52(1), 43-52, 2012
15
Effect of antimicrobial residues on early adhesion and biofilm formation by wild-type and benzalkonium chloride-adapted Pseudomonas aeruginosa
  • BIOFOULING, 27(10), 1151-1159, 2011
16
Role of planktonic and sessile extracellular metabolic byproducts on Pseudomonas aeruginosa and Escherichia coli intra and interspecies relationships
  • JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY, 38(1), 133-140, 2011
17
Time to "go large" on biofilm research: advantages of an omics approach
  • Biotechnology Letters, 31(4), 477-485, 2009
Full List